WallStreetZenWallStreetZen

NASDAQ: ELOX
Eloxx Pharmaceuticals Inc Stock

Open Broker Account
$2.81-0.60 (-17.6%)
Updated Dec 8, 2022
ELOX Price
$2.81
Fair Value Price
$969.45
Market Cap
$6.09M
52 Week Low
$2.74
52 Week High
$40.40
P/E
-0.16x
P/B
-1.22x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$41.84M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-6.4
Operating Cash Flow
-$36M
Beta
1.35
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

ELOX Overview

Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis patients with diagnosed nonsense mutations. The company also develops various preclinical programs for the treatment of alport syndrome, recessive dystrophic epidermolysis bullosa, junctional epidermolysis bullosa, and familial adenomatous polyposis, as well as various earlier discovery stage programs in oncology. Eloxx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Watertown, Massachusetts.

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ELOX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ELOX ($2.81) is undervalued by 99.71% relative to our estimate of its Fair Value price of $969.45 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
ELOX ($2.81) is significantly undervalued by 99.71% relative to our estimate of its Fair Value price of $969.45 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
ELOX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ELOX due diligence checks available for Premium users.

Be the first to know about important ELOX news, forecast changes, insider trades & much more!

ELOX News

Valuation

ELOX fair value

Fair Value of ELOX stock based on Discounted Cash Flow (DCF)
Price
$2.81
Fair Value
$969.45
Undervalued by
99.71%
ELOX ($2.81) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ELOX ($2.81) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ELOX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ELOX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.16x
Industry
13.31x
Market
21.39x

ELOX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-1.22x
Industry
4.98x

ELOX's financial health

Profit margin

Revenue
$0.0
Net Income
-$7.5M
Profit Margin
0%
ELOX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$26.9M
Liabilities
$31.9M
Debt to equity
-6.4
ELOX's short-term assets ($25.67M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ELOX's short-term assets ($25.67M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ELOX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ELOX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$6.9M
Investing
-$48.0k
Financing
$1.5M
ELOX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ELOX vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ELOX$6.09M-17.55%-0.16x-1.22x
ADIL$6.20M+1.76%-0.33x1.15x
NBSE$6.23M-3.50%-0.19x0.21x
MTP$5.95M-1.31%-1.77x0.70x
TENX$6.26M-1.41%-0.38x1.58x

Eloxx Pharmaceuticals Stock FAQ

What is Eloxx Pharmaceuticals's quote symbol?

NASDAQ: ELOX) Eloxx Pharmaceuticals trades on the NASDAQ under the ticker symbol ELOX. Eloxx Pharmaceuticals stock quotes can also be displayed as NASDAQ: ELOX.

If you're new to stock investing, here's how to buy Eloxx Pharmaceuticals stock.

What is the 52 week high and low for Eloxx Pharmaceuticals (NASDAQ: ELOX)?

(NASDAQ: ELOX) Eloxx Pharmaceuticals's 52-week high was $40.40, and its 52-week low was $2.74. It is currently -93.04% from its 52-week high and 2.55% from its 52-week low.

How much is Eloxx Pharmaceuticals stock worth today?

(NASDAQ: ELOX) Eloxx Pharmaceuticals currently has 2,166,406 outstanding shares. With Eloxx Pharmaceuticals stock trading at $2.81 per share, the total value of Eloxx Pharmaceuticals stock (market capitalization) is $6.09M.

Eloxx Pharmaceuticals stock was originally listed at a price of $245,000.00 in Apr 26, 1999. If you had invested in Eloxx Pharmaceuticals stock at $245,000.00, your return over the last 23 years would have been -100%, for an annualized return of -39.02% (not including any dividends or dividend reinvestments).

How much is Eloxx Pharmaceuticals's stock price per share?

(NASDAQ: ELOX) Eloxx Pharmaceuticals stock price per share is $2.81 today (as of Dec 8, 2022).

What is Eloxx Pharmaceuticals's Market Cap?

(NASDAQ: ELOX) Eloxx Pharmaceuticals's market cap is $6.09M, as of Dec 10, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Eloxx Pharmaceuticals's market cap is calculated by multiplying ELOX's current stock price of $2.81 by ELOX's total outstanding shares of 2,166,406.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.